 | Up a level |
Number of items: 1.
Loong, H. H. F., Goto, K., Elamin, Y. Y., Solomon, B., Santini, F. C., Soldatenkova, V., Sashegyi, A., Lin, A. Bence, Lin, B. K., Wolf, J., Oxnard, G. R., Zhou, C., Drilon, A. and Park, K. (2020). LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET plus ) non-small cell lung cancer (NSCLC). Ann. Oncol., 31. S. S893 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041